title: Reply to Saliou et al.
authors.forename: Charlotte J
authors.initials: CJ
authors.lastname: Verfaillie
authors.forename: Marco J
authors.initials: MJ
authors.lastname: Bruno
authors.forename: Anne F
authors.initials: AF
authors.lastname: Voor In 't Holt
authors.forename: Jolanda G
authors.initials: JG
authors.lastname: Buijs
authors.forename: Jan-Werner
authors.initials: JW
authors.lastname: Poley
authors.forename: Arjo J
authors.initials: AJ
authors.lastname: Loeve
authors.forename: Juliette A
authors.initials: JA
authors.lastname: Severin
authors.forename: Leo F
authors.initials: LF
authors.lastname: Abel
authors.forename: Bert J
authors.initials: BJ
authors.lastname: Smit
authors.forename: Inge
authors.initials: I
authors.lastname: de Goeij
authors.forename: Margreet C
authors.initials: MC
authors.lastname: Vos
mesh_terms: D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000295:instrumentation*; D003428:Cross Infection / Q000517:prevention & control*; D004196:Disease Outbreaks / Q000517:prevention & control*; D020698:Duodenoscopes / Q000382:microbiology*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*